Nyce J, Liu L, Jones P A
Nucleic Acids Res. 1986 May 27;14(10):4353-67. doi: 10.1093/nar/14.10.4353.
Post-synthetic enzymatic hypermethylation of DNA was induced in hamster fibrosarcoma cells by the DNA synthesis inhibitors cytosine arabinoside, hydroxyurea and aphidicolin. This effect required direct inhibition of DNA polymerase alpha or reduction in deoxynucleotide pools and was not specific to a single cell type. At equivalently reduced levels of DNA synthesis, neither cycloheximide, actinomycin D nor serum deprivation affected DNA methylation in this way. The topoisomerase inhibitors nalidixic acid and novobiocin caused significant hypomethylation indicating that increased 5-mCyt content was not a necessary consequence of DNA synthesis inhibition. The induced hypermethylation occurred predominantly in that fraction of the DNA synthesized in the presence of inhibitor; was stable in the absence of drug; was most prominent in low molecular weight DNA representing sites of initiated but incomplete DNA synthesis; and occurred primarily within CpG dinucleotides, although other dinucleotides were overmethylated as well. Drug-induced CpG hypermethylation may be capable of silencing genes, an effect which may be relevant to the aberrantly expressed genes characteristic of neoplastic cells.
DNA合成抑制剂阿糖胞苷、羟基脲和阿非迪霉素可诱导仓鼠纤维肉瘤细胞发生DNA合成后酶促超甲基化。这种效应需要直接抑制DNA聚合酶α或降低脱氧核苷酸池水平,且并非单一细胞类型所特有。在DNA合成水平同等降低的情况下,环己酰亚胺、放线菌素D或血清剥夺均不会以这种方式影响DNA甲基化。拓扑异构酶抑制剂萘啶酸和新生霉素可导致显著的低甲基化,表明5-甲基胞嘧啶含量增加并非DNA合成抑制的必然结果。诱导的超甲基化主要发生在抑制剂存在时合成的那部分DNA中;在无药物时稳定;在代表起始但未完成DNA合成位点的低分子量DNA中最为显著;并且主要发生在CpG二核苷酸内,尽管其他二核苷酸也会发生超甲基化。药物诱导的CpG超甲基化可能能够使基因沉默,这种效应可能与肿瘤细胞特征性异常表达的基因有关。